How is liver disease diagnosed?
Is Your Liver Healthy?
Learn about common misconceptions and the pathway that you might experience to investigate and evaluate your liver's health with your health care team. Our host, Jeff McIntyre, is joined by Dr. Julia Wattacheril, MASLD Director at Columbia NewYork-Presbyterian Hospital and expert clinician and researcher, to zoom out and illuminate the big picture of liver health as well as the process and techniques that you might encounter. With as many as one in three people in the world experiencing liver disease (especially metabolic dysfunction-associated steatotic liver disease, known as MASLD and...
info_outline
Getting Out of Our Own Way: Hepatitis C Elimination
Is Your Liver Healthy?
With the technical tools to eliminate viral hepatitis C available, focus must now be directed on garnering the political will to fund elimination efforts and deploying a harm reduction approach that can meaningfully impact affected populations by meeting them where they are and preventing damage to liver health and well-being before it happens. In this month's episode of Is Your Liver Healthy?, guest host Gina Bartes, Vice President at Global Liver Institute, is joined by Dr. Beth Meyerson, director of the and Beverly Benson McCord Endowed Chair of Nursing at the University of...
info_outline
The Power of Liver Transplantation
Is Your Liver Healthy?
Why are organ donation and transplantation so important to people with liver disease? Hear from a pediatric transplant recipient and her transplant surgeon on the process, the challenges, and the importance of organ donation to community well-being! This month's guests: Sophie Hansen, 2x Liver Transplant Recipient Dr. Manuel Rodriguez-Davalos, Transplant Hepatologist & President of the
info_outline
GLP-1s & Your Liver
Is Your Liver Healthy?
GLP-1s, or glucagon-like peptide-1 receptor agonists, are a class of medications used to treat type 2 diabetes, obesity, kidney disease, and other conditions. These drugs mimic GLP-1, a hormone that affects insulin release, slows stomach emptying, and affects satiety. Early studies suggest that GLP-1 drugs can benefit liver health as well. Explore the basics and what liver patients should know about GLP-1s with this month's guests: Joe Naglowski, President & CEO, Dr. Janese Laster, Gastroenterologist & founder of
info_outline
Rare & Rural Access to Care and Research
Is Your Liver Healthy?
Patients with rare (liver) diseases need access to clinical trials, but those in rural areas lack access due to structural and geographic barriers – which affects opportunities and generalizability of data for everyone. This Rare Liver Diseases Month, GLI is focusing on the issues affecting Rare & Rural communities. In this episode, hear from our guests on the challenges for rare & rural liver disease patients in their communities. Learn about our guests & their upcoming events: Dr. Harsha Rajasimha - Dr. Cecilia Dueñas - Teresa Davidson - Kristin...
info_outline
The Global State of Liver Health
Is Your Liver Healthy?
Liver diseases pose a serious threat to communities all over the world. The scientific and medical community have many of the tools to treat and prevent liver disease, but a political will to operationalize programs to prevent, diagnose, and treat these diseases is necessary to turn the tide. In this episode of "Is Your Liver Healthy?" guests from around the world join our host, Jeff McIntyre, to discuss the recently released and talk about what's next in their communities to improve liver health. Guests this episode: José Willemse, Former Executive Director & Patient...
info_outline
Welcome to “Is Your Liver Healthy?”
Is Your Liver Healthy?
In "Is Your Liver Healthy?" the team at Global Liver Institute (GLI) bring stories about the factors and forces that affect liver health to liver patients and their loved ones. In this preview episode, our host Jeff McIntyre invites staff from GLI, who will appear on future episodes, to introduce themselves and cast a vision for liver health in 2025. Learn more about GLI and our work at
info_outlineGLP-1s, or glucagon-like peptide-1 receptor agonists, are a class of medications used to treat type 2 diabetes, obesity, kidney disease, and other conditions. These drugs mimic GLP-1, a hormone that affects insulin release, slows stomach emptying, and affects satiety. Early studies suggest that GLP-1 drugs can benefit liver health as well. Explore the basics and what liver patients should know about GLP-1s with this month's guests:
- Joe Naglowski, President & CEO, Obesity Action Coalition
- Dr. Janese Laster, Gastroenterologist & founder of Gut Theory Total Digestive Care